Medical News

RSS

Metabolon announces publication of Ablation of Locus Coeruleus in Tg-2576 transgenic mice

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Ablation of the Locus Coeruleus (LC) Increases Oxidative Stress in Tg-2576 Transgenic But Not Wild-type Mice" in the International Journal of Alzheimer Disease.

14 Oct 2010

Health care workforce faces strains, shifts

Kaiser Health News / NPR "Last year, half of new doctors were hired by hospitals, according to the Medical Group Management Association, a professional organization for physician practices. According to a 2009 report by the American Medical Association, one in six doctors works for a hospital, and the number is quickly growing.

14 Oct 2010

Federal guidance aims to reduce misuse of synthetic DNA to create dangerous organisms

Federal guidance issued today aims to reduce the risk that synthetic DNA will be misused deliberately to create dangerous organisms. Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, issued by the U.S. Department of Health and Human Services, supports national biosecurity goals and balances the promise of synthetic DNA with its potential biosecurity risks.

14 Oct 2010

Risingsun signs consent decree to stop selling unapproved drugs

The U.S. Food and Drug Administration today announced that Toby McAdam and Greta Armstrong, doing business as Risingsun Health and The Center for Complimentary and Alternative Health of Livingston, Montana, have signed a consent decree that prohibits them from manufacturing and selling unapproved new drugs and adulterated or misbranded dietary supplements in violation of the law.

14 Oct 2010

Forum allows healthcare professionals to consider probiotics for patient wellbeing

GPs who have a chance to evaluate the current evidence on probiotics and hear from experts firsthand on their relevance to clinical practice are much more likely to consider them, according to the findings of an interactive debate at the RCGPs Annual Primary Care Conference in Harrogate this week.

14 Oct 2010

Plant compound luteolin reduces age-associated inflammation in brain leading to better cognitive health

A diet rich in the plant compound luteolin reduces age-related inflammation in the brain and related memory deficits by directly inhibiting the release of inflammatory molecules in the brain, researchers report.

14 Oct 2010

World's third rectal microbicide trial launched in Pittsburgh

The world's third rectal microbicide trial launched in Pittsburgh, Pennsylvania today, with sites preparing to open in Boston, Massachusetts, and Birmingham, Alabama soon. Scientists will test the rectal safety and acceptability of tenofovir gel, a microbicide developed for vaginal use that has shown promise for preventing HIV through vaginal intercourse. Depending on the outcome of this new study, tenofovir gel could be further evaluated to determine if it can reduce the risk of HIV among both men and women who engage in receptive anal intercourse.

14 Oct 2010

Insurance companies denied policies to 1 of every 7 applicants, probe finds

The Wall Street Journal: The four largest for-profit health insurers in the U.S. -- Aetna Inc., Humana Inc., UnitedHealth Group Inc., and WellPoint Inc. -- "on average denied policies to one out of every seven applicants based on their prior medical history," according to a congressional investigative report released yesterday by Henry Waxman (D-Calif.), chairman of the House Energy and Commerce Committee, and Rep. Bart Stupak (D-Mich.).

14 Oct 2010

World Food Prize symposium to give out award; focus on issues facing smallholder farmers

Global agriculture officials and as many as 60 farmers from around the world this week at the annual World Food Prize symposium in Des Moines, Iowa will focus on the challenges facing small farmers, the Associated Press reports.

14 Oct 2010

Yoga program improves fibromyalgia symptoms and functional deficits

Fibromyalgia (FM) is a debilitating condition affecting 11󈝻 million individuals in the US alone. FM carries an annual direct cost for care of more than $20 billion and drug therapies are generally only 30% effective in relieving symptoms and 20% effective in improving function. Standard care currently includes medications accompanied by exercise and coping skills approaches. In a study published in the November 2010 issue of PAIN, researchers report patients participating in a "Yoga of Awareness" program showed significantly greater improvement in FM symptoms and functioning compared to patients on a standard FM care program.

14 Oct 2010

GSK to expand donation of albendazole medicine to treat children with STH risk

At the launch of the World Health Organization's (WHO) first report on Neglected Tropical Diseases today, GSK announced a new five year commitment to expand the donation of its medicine albendazole to treat children at risk of intestinal worms, known as soil-transmitted helminths (STH).

14 Oct 2010

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Balaji Sitharaman, Ph.D., Assistant Professor of Biomedical Engineering at Stony Brook University, is a 2010 recipient of the National Institutes of Health (NIH) Director's New Innovator Award.

14 Oct 2010

'Keyhole' procedure safer than invasive approaches in removing acoustic neuroma without hearing loss

Results from a newly released 9-year study is bringing newfound hope to the approximately 3,000 Americans diagnosed each year with acoustic neuromas (AN), little-known brain tumors that can have devastating and even fatal consequences for sufferers.

14 Oct 2010

Anger, seniors and Ad campaigns: Health reform politics

A poll released Tuesday shows most seniors in Medicare's prescription drug benefit program don't know that the health law "closes Part D's coverage gap," The Hill's Healthwatch blog reports.

14 Oct 2010

AACE publishes consensus statement for continuous glucose monitoring

The American Association of Clinical Endocrinologists (AACE) today published a consensus statement for continuous glucose monitoring (CGM) online, and the statement will be published in the next issue of the association's official medical journal Endocrine Practice.

14 Oct 2010

Osteotech granted early termination of Hart-Scott-Rodino waiting period for proposed Medtronic merger

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has received notification that the U.S. Department of Justice and Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period for its proposed merger with Medtronic, Inc.

14 Oct 2010

Workshop to focus on FDA process that grants orphan drug designation

The U.S. Food and Drug Administration has scheduled the third in a series of workshops on orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process for Nov. 4-5, 2010, in Lansdowne, Va.

14 Oct 2010

Justices wrestle with issue of protecting vaccine makers

The Supreme Court is grappling with the question of how much protection the 1986 National Childhood Vaccine Injury Act was meant to provide vaccine manufacturers against lawsuits. The case involves Hannah Bruesewitz, whose parents claim that a Wyeth-manufactured D.T.P. vaccine she received as an infant in 1992 led to developmental problems.

14 Oct 2010

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm Inc. today announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics (SPC) and other labeling documents.

14 Oct 2010

Drugs that restore mitochondria function may treat Alzheimer's disease at early stages: Research

Before Alzheimer's patients experience memory loss, the brain's neurons have already suffered harm for years. A new study in mouse models by researchers at Columbia University Medical Center has found that the brain's mitochondria, the powerhouses of the cell, are one of the earliest casualties of the disease. The study, which appeared in the online Early Edition of PNAS, also found that impaired mitochondria then injure the neurons' synapses, which are necessary for normal brain function.

14 Oct 2010

Medical News

Metabolon announces publication of Ablation of Locus Coeruleus in Tg-2576 transgenic mice

Health care workforce faces strains, shifts

Federal guidance aims to reduce misuse of synthetic DNA to create dangerous organisms

Risingsun signs consent decree to stop selling unapproved drugs

Forum allows healthcare professionals to consider probiotics for patient wellbeing

Plant compound luteolin reduces age-associated inflammation in brain leading to better cognitive health

World's third rectal microbicide trial launched in Pittsburgh

Insurance companies denied policies to 1 of every 7 applicants, probe finds

World Food Prize symposium to give out award; focus on issues facing smallholder farmers

Yoga program improves fibromyalgia symptoms and functional deficits

GSK to expand donation of albendazole medicine to treat children with STH risk

Stony Brook professor receives 2010 NIH Director's New Innovator Award

'Keyhole' procedure safer than invasive approaches in removing acoustic neuroma without hearing loss

Anger, seniors and Ad campaigns: Health reform politics

AACE publishes consensus statement for continuous glucose monitoring

Osteotech granted early termination of Hart-Scott-Rodino waiting period for proposed Medtronic merger

Workshop to focus on FDA process that grants orphan drug designation

Justices wrestle with issue of protecting vaccine makers

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Drugs that restore mitochondria function may treat Alzheimer's disease at early stages: Research

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News